Synoptis Pharma
Purps
Synoptis Pharma THC 22%
A hybrid strain from Synoptis Pharma with a majority of indica genes (approx. 70%), distinguished by deep, calming effects and an intense aroma. Dense, resinous flowers with darker coloring and an earthy-floral scent. The flavor profile is dominated by earthy notes with a distinct floral accent and slightly sharp finish. Ideal for late afternoon and evening. Terpene profile with dominant nerolidol and caryophyllene.

Product information
- Producer
- Synoptis Pharma
- THC / CBD
- 22% / ≤1%
- Packaging
- 15g
- Product code (EAN/GTIN)
- No verified code in the catalogue
- GdziePoLek ID (not EAN)
- 129848
- Availability
- Unconfirmed
- Availability updated
- 12/11/2026, 21:44:58
Catalogue terpene profile
| Terpene | Profile (%) |
|---|---|
| Caryophyllene | 25 |
| Nerolidol | 24 |
| Limonene | 11 |
| Bisabolol | 11 |
| Humulene | 9 |
| Linalool | 8 |
| Myrcene | 6 |
| Pinene | 5 |
| Ocimene | 1 |
Profile values are not terpene concentrations in the flower or a batch-specific certificate of analysis (COA). Verify the product, strength, packaging and code in the current registry or product documentation before prescribing. Availability may change.
Portugal
Nerolidol
Limonene
Bisabolol
Humulene
Linalool
Myrcene
Pinene
Ocimene